Literature DB >> 20350904

W(h)ither metreleptin for lipodystrophy and the metabolic syndrome?

Christos S Mantzoros.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20350904     DOI： 10.4158/EP10038.ED

Source DB:  PubMed          Journal:  Endocr Pract        ISSN： 1530-891X            Impact factor:   3.443


× No keyword cloud information.
  8 in total

Review 1.  Lipodystrophy: pathophysiology and advances in treatment.

Authors:  Christina G Fiorenza; Sharon H Chou; Christos S Mantzoros
Journal:  Nat Rev Endocrinol       Date:  2010-11-16       Impact factor: 43.330

Review 2.  Metreleptin: first global approval.

Authors:  Ken Chou; Caroline M Perry
Journal:  Drugs       Date:  2013-06       Impact factor: 9.546

Review 3.  Leptin in human physiology and pathophysiology.

Authors:  Christos S Mantzoros; Faidon Magkos; Mary Brinkoetter; Elizabeth Sienkiewicz; Tina A Dardeno; Sang-Yong Kim; Ole-Petter R Hamnvik; Anastasia Koniaris
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-07-26       Impact factor: 4.310

Review 4.  Leptin in human physiology and therapeutics.

Authors:  Tina A Dardeno; Sharon H Chou; Hyun-Seuk Moon; John P Chamberland; Christina G Fiorenza; Christos S Mantzoros
Journal:  Front Neuroendocrinol       Date:  2010-06-17       Impact factor: 8.606

5.  Efficacy of metreleptin in obese patients with type 2 diabetes: cellular and molecular pathways underlying leptin tolerance.

Authors:  Hyun-Seuk Moon; Giuseppe Matarese; Aoife M Brennan; John P Chamberland; Xiaowen Liu; Christina G Fiorenza; Geetha H Mylvaganam; Luisa Abanni; Fortunata Carbone; Catherine J Williams; Alex M De Paoli; Benjamin E Schneider; Christos S Mantzoros
Journal:  Diabetes       Date:  2011-06       Impact factor: 9.461

Review 6.  Leptin as a modulator of neuroendocrine function in humans.

Authors:  Sami M Khan; Ole-Petter R Hamnvik; Mary Brinkoetter; Christos S Mantzoros
Journal:  Yonsei Med J       Date:  2012-07-01       Impact factor: 2.759

7.  Leptin in relation to the lipodystrophy-associated metabolic syndrome.

Authors:  Christos S Mantzoros
Journal:  Diabetes Metab J       Date:  2012-06-14       Impact factor: 5.376

Review 8.  Leptin's role in lipodystrophic and nonlipodystrophic insulin-resistant and diabetic individuals.

Authors:  Hyun-Seuk Moon; Maria Dalamaga; Sang-Yong Kim; Stergios A Polyzos; Ole-Petter Hamnvik; Faidon Magkos; Jason Paruthi; Christos S Mantzoros
Journal:  Endocr Rev       Date:  2013-03-08       Impact factor: 19.871
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.